Agios Pharmaceuticals said tebapivat fell short of expectations in a Phase 2 test in sickle cell disease. It’s the latest in a series of disappointing industry developments in sickle cell disease. The post Agios Pharma Drops Sickle Cell Disease Drug After Phase 2 Data Disappoint appeared first on MedCity News.
Screening for mental health symptoms in patients with significant allergic disease is not overreach The post How Diagnostic Precision in Allergy Care Supports Mental Well-Being appeared first on MedCity News.
Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction. The post Why Pharma Companies Should Look To Social Media For Better Patient Insight appeared first on MedCity News.
[Sponsored] A five minute survey from MedCity News asks payers what they think of AI and how it is being implemented. Participate today and we will reward you! The post Where Will AI Deployment Benefit Payers the Most? appeared first on MedCity News.
As hospitals increasingly use AI to improve patient care, the same technology is being used by hackers and nation-states to launch faster, more sophisticated attacks. Karen Habercoss, chief information security and privacy officer at the University of Chicago Medicine, explained how her health system is building a governance structure to manage that risk. The post…
A new report from the Peterson Health Technology Institute argues that today’s healthcare payment models are ill-suited for clinical AI and could drive up costs. The post How Should Clinical AI Be Paid For? 3 Takeaways appeared first on MedCity News.
Personalis’s liquid biopsy is part of a growing market for minimal residual disease assays, tests that look for any remaining cancer cells after the initial treatment. Tempus AI has been the commercial partner on this Personalis test since 2023. The post Expecting Massive Test Growth in Cancer & More, Tempus AI Strikes $1.5B Deal to…
These three legal regimes are pulling in different directions, and the developers that navigate them well will be the ones that plan for all three from the start. The post The AI Tension in Healthcare: Patent Strategy, FDA Reality, and HIPAA Constraints appeared first on MedCity News.
Rural Health Transformation Program funding gives states broad flexibility and may help address longstanding access gaps. The post For Millions in Rural America, Medicine Is Still Far Away appeared first on MedCity News.
A new PwC report says the women’s oncology market could reach $110 billion by 2030, though funding and care gaps remain. The post Women’s Oncology Market Could Reach $110B in 2030, but Gaps Remain appeared first on MedCity News.